ORIGINAL RESEARCH
Published on 22 Sep 2025
Efficacy and safety of immune checkpoint inhibitor rechallenge therapy in the treatment of advanced acquired immune-resistant non-small cell lung cancer: a retrospective study
doi 10.3389/fonc.2025.1621860
- 654 views